#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor VIII deficiency Paget's disease of the vulva Hereditary angioedema Myasthenia gravis Mantle cell lymphoma stage III Renal cancer metastatic Acute lymphocytic leukaemia recurrent Subarachnoid haemorrhage Squamous cell carcinoma of the hypopharynx Neuroendocrine tumour Adenocarcinoma pancreas Myelodysplastic syndrome with excess blasts Colorectal adenocarcinoma Follicle centre lymphoma follicular grade I, II – III Microvillous inclusion disease More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease Osteosarcoma metastatic – Life with Disease Familial amyotrophic lateral sclerosis – Trials in Disease Osteosarcoma recurrent – Diagnostics Short-bowel syndrome – Treatment Progressive multifocal leukoencephalopathy – Trials in Disease Indolent systemic mastocytosis Gaucher’s disease type III – Diagnostics Angelman’s syndrome – Basic Information Hereditary motor and sensory neuropathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ht-29-A Brexpiprazole Apl-101 Colchicine Adrenaline Tartrate Ph. Eur. Antithrombin Iii Human Retinol Acetate Tiragolumab ALXN1920 Amivantamab Midomafetamine Hydrochloride Neflamapimod Tanimilast Cefiderocol GAXILOSE Rilpivirine LY3841136 SODIUM L-PROLINE Repagermanium Omp72 More therapies…

    Learn about Your Condition

    Endocrine ophthalmopathy Bartonellosis Myotonic dystrophy Primary hyperthyroidism Diabetic foot Vertigo Ovarian epithelial cancer Gouty arthritis Colorectal cancer metastatic Haemodialysis Biliary tract disorder Knee arthroplasty Neuroendocrine carcinoma Non-small cell lung cancer Post-traumatic stress disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina…

Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina W Rzeszowie

Ucj Fndtqjijt Spdsmjk 2g Rpobojjo 3fdpezh Pqebbk

Want to learn more about this study or check if you can participate? Contact us.

  • Phase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    • Subacute cutaneous lupus erythematosus
    Belgium Bulgaria France Germany Greece Italy +4

  • Comparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Tucatinib
    • Trastuzumab
    Austria Belgium Czechia France Germany Hungary +5

  • A study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Zasocitinib
    Germany Italy Poland Spain

  • A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cold urticaria
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Germany Lithuania Poland Spain

  • Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Ustekinumab
    • Deucravacitinib
    Belgium Bulgaria Czechia Denmark France Germany +6

  • A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Investigated Drugs:
    • Bimekizumab
    Czechia Denmark France Germany Hungary Italy +2

  • Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Germany The Netherlands Poland Spain

  • Long-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031

    Recruiting

    3 1
    Czechia France Italy Poland Spain

  • Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

    Recruiting

    3 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Ruxolitinib
    Austria Belgium Bulgaria Denmark France Germany +6

  • Study of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus

    Recruiting

    2 1
    Investigated Drugs:
    • VENT-03
    Bulgaria Czechia France Hungary Poland Spain
1 2 3 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!